TransCardiac Therapeutics
Atlanta · Founded 2003
About TransCardiac Therapeutics
TransCardiac Therapeutics develops technologies to facilitate access to the human heart.
Company Facts
- Founded: 2003
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $200.0K
- Funding stage: Seed
- Last round: Seed (Jul 2009)
- Website: transcardiac.com
- Phone: 404-816-4520
Canonical: https://fsome.com/organization/transcardiac-therapeutics-8275280 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.